Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

Herantis Pharma

2.01 EUR

-3.37 %

4,550 following
Corporate customer

HRTIS

First North Finland

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Investor consensus
Valuation
Income statement
Quarterly estimates

Income statement

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Herantis Pharma

20182019202020212022202320242025e2026e2027e2028e
Revenue0.00.00.00.00.00.00.00.00.00.00.0
growth-%150.0 %
EBITDA-8.5-9.7-8.10.2-5.0-5.5-6.6-11.2-11.5
EBIT (adj.)-8.1-12.5-8.00.2-5.0-5.5-6.6-11.2-11.5
EBIT-8.1-12.5-8.00.2-5.0-5.5-6.6-11.2-11.5
Profit before taxes-8.6-12.8-9.30.3-5.0-6.0-6.6-11.2-11.5
Net income-8.6-12.8-9.30.3-5.0-6.0-6.6-11.2-11.5
EPS (adj.)-0.88-1.15-0.550.01-0.25-0.25-0.28-0.46-0.48
growth-%-1,895.3 %
Dividend0.000.000.000.000.000.000.000.000.000.000.00
Dividend ratio

Profitability and return on capital

20182019202020212022202320242025e2026e2027e2028e
EBITDA-%-213,375.0 %-243,525.0 %-201,825.0 %3,850.0 %-50,270.0 %-55,119.0 %-66,408.0 %-111,995.0 %-115,100.0 %
EBIT-% (adj.)-201,775.0 %-311,525.0 %-199,825.0 %3,850.0 %-50,270.0 %-55,119.0 %-66,408.0 %-111,995.0 %-115,100.0 %
EBIT-%-201,775.0 %-311,525.0 %-199,825.0 %3,850.0 %-50,270.0 %-55,119.0 %-66,408.0 %-111,995.0 %-115,100.0 %
ROE-226.6 %-396.1 %1,541.2 %12.0 %-226.5 %752.5 %143.6 %82.7 %46.2 %
ROI-109.1 %-119.5 %-151.8 %3.3 %-222.0 %-443.3 %-442.7 %-4,479.8 %-4,604.0 %
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.